Short Active Lives Survey in Chronic Lung Conditions
- Conditions
- Lung Diseases
- Registration Number
- NCT04080583
- Lead Sponsor
- University of Lincoln
- Brief Summary
Short Actives Lives Survey is a common tool used to measure physical activity in the UK population. Self-reported measures such as the Short Active Lives Survey can be prone to bias. As such, during project evaluations, benefits may be exaggerated due to over-reporting of physical activity or downplayed due to underreporting of physical activity. There is also a lack of research reporting the typical short-term and long-term changes in physical activity (measured by the Short Active Lives Survey) in people with chronic lung conditions who are not receiving support to become active (i.e. usual care, control groups). Accelerometers are small lightweight activity monitors that can be worn on the waist. These monitors are known to provide accurate and reliable objective assessment of physical activity in people with lung conditions.
This research study will recruit a cohort of inactive people with lung conditions and determine changes in physical activity measured by both the Short Active Lives Survey and one of the most valid accelerometers used in people with lung conditions (Actigraph GT3X). The study will also evaluate how these physical activity measures relate to general health (health status and health care use) of people with lung conditions over 12 months. This study will provide information on the usefulness of using the Short Active Lives Survey in the future for measuring physical activity in people with lung conditions.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
- Diagnosis of Chronic Obstructive Pulmonary Disease, Bronchiectasis, Interstitial Lung Disease, Lung Cancer, Mesothelioma or Asthma
- Physically inactive defined as completing less than 30 minutes ore more of moderate intensity equivalent physical activity per week (measured by the Short Active Lives Survey)
- Adults without a diagnosis of Chronic Obstructive Pulmonary Disease, Bronchiectasis, Interstitial Lung Disease, Lung Cancer, Mesothelioma or Asthma
- Age < 18 Years
- Completing 30 minutes or more of moderate intensity equivalent (MIE) physical activity per week
- Inability or unwillingness to sign informed consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Minutes of self-reported moderate intensity equivalent physical activity per week Baseline to 12 months Short Active Lives Survey
- Secondary Outcome Measures
Name Time Method Accelerometer measured physical activity: time (minutes per week) spent in light activity Baseline to 12 months Actigraph wGT3X-BT
Accelerometer measured physical activity including: time (minutes per week) spent in vigorous activity Baseline to 12 months Actigraph wGT3X-BT
Accelerometer measured physical activity: time (minutes per day) spent in moderate intensity activity Baseline to 12 months Actigraph wGT3X-BT
Accelerometer measured physical activity: time (minutes per day) spent in sedentary state Baseline to 12 months Actigraph wGT3X-BT
EQ VAS Baseline to 12 months Self-report of health status on a scale, 0 (worst health) - 100 (best health)
Accelerometer measured physical activity: average daily steps Baseline to 12 months Actigraph wGT3X-BT
Accelerometer measured physical activity including: daily vector magnitude units Baseline to 12 months Actigraph wGT3X-BT
Cost questionnaire Baseline to 12 months NHS resource use questionnaire
EQ5D index Baseline to 12 months Based on self-rating of five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression). Each dimension is rated between 1 (no problems) to 5 (unable to/extreme problems). Dimensions are combined to produce a five-digit number describing the individual's health status (ranging from 11111 to 55555). Five digit number converted to an index based on the EQ-5D-5L value set for England. Index ranges from -0.208 (worst possible health) to 1.000 (best possible health).
Demographics: Baseline to 12 months Age, gender, ethnicity, comorbidities, social deprivation, MRC degree of breathlessness, oxygen use
Trial Locations
- Locations (1)
University of Lincoln
🇬🇧Lincoln, Lincolnshire, United Kingdom